Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.350
+0.090 (7.14%)
At close: Mar 12, 2026, 4:00 PM EDT
1.315
-0.035 (-2.60%)
After-hours: Mar 12, 2026, 4:33 PM EDT

Allarity Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-24.1-24.52-11.9-16.06-26.65-6.62
Depreciation & Amortization
0.030.010.040.060.110.05
Stock-Based Compensation
0.750.41-0.071.756.370.62
Other Adjustments
2.066.68-4.16-2.24-0.28-1.74
Change in Receivables
-----0.1
Changes in Accounts Payable
-3.1-4.112.176.21-1.31-0.06
Changes in Accrued Expenses
1.343.540.04-4.727.2-0.04
Changes in Income Taxes Payable
0.020.020.02-0.020.010.03
Changes in Unearned Revenue
-0.21----
Changes in Other Operating Activities
-1.010.411.13-1.79-0.320.42
Operating Cash Flow
-16.82-17.35-12.75-16.82-14.89-7.25
Capital Expenditures
--0.3--0.02--0
Proceeds from Sale of Intangible Assets
---0.811.01-
Investing Cash Flow
--0.3-0.791.01-0
Long-Term Debt Issued
-1.341.05143
Long-Term Debt Repaid
--1.34-3.7--2.95-0.53
Net Long-Term Debt Issued (Repaid)
---2.6511.052.47
Issuance of Common Stock
26.3837.3519.14-32.853.48
Repurchase of Common Stock
-1.28-----
Net Common Stock Issued (Repurchased)
25.137.3519.14-32.853.48
Issuance of Preferred Stock
-2.941.16---
Repurchase of Preferred Stock
--3.5-6.65-2.31--
Net Preferred Stock Issued (Repurchased)
--0.56-5.49-2.31--
Other Financing Activities
-----0.080.08
Financing Cash Flow
17.6836.7911-1.3133.826.03
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-2.340.23-0.11-0.19-0.68-0.01
Net Cash Flow
0.8719.14-1.75-17.3419.94-1.22
Free Cash Flow
-16.82-17.65-12.75-16.84-14.89-7.25
Free Cash Flow Per Share
-2.06-10.98-3765.14-29708.82-49159.54-1866392.22
Levered Free Cash Flow
-27.37-25.38-19.68-20.34-19.92-3.74
Unlevered Free Cash Flow
-29.94-27.88-13.62-31.77-20.75-8.18
Updated Aug 15, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q